The health tech and medtech investment landscape in the age of Covid-19
Fredrikson & Byron attorneys Ryan Johnson and Jeffrey Steinle share insights on how Covid-19 is continuing to transform the health tech and medtech landscape.
MedCity Spotlight Video: Fredrikson & Byron attorneys discuss Covid-19’s impact on deal-making and value-based care
In a Spotlight Video interview, Fredrikson & Byron Shareholders and Co-chairs of the firm's life sciences group, Jeff Steinle and Ryan Johnson, talked about the deal-making environment in healthcare and how the Covid-19 pandemic has impacted it.
Why Pharma Companies Should Look To Social Media For Better Patient Insight
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.
The legal and regulatory landscape for digital health companies
Q&A with Fredrikson & Byron attorneys Ryan Johnson and Jeff Steinle